Valuation: Monto Minerals Ltd

Market Cap 81.89M 58.71M 50.27M 46.99M 43.01M 80.77M 5.62B 556M 217M 2.82B 220M 216M 9.33B P/E 2024
-1.36x
P/E 2025 -3.77x
Enterprise Value 81.87M 58.69M 50.26M 46.97M 43M 80.74M 5.62B 555M 217M 2.82B 220M 216M 9.33B EV / Sales 2024
9.78x
EV / Sales 2025 21.1x
Free-Float
59.45%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/01/1994
Chief Executive Officer - 11/05/2026
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 21/10/2025
Director/Board Member - 21/10/2025
Chairman - 26/11/2025
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-1.88%-12.72%+32.59% 40.7B
-6.99%+4.29%-37.71%+173.32% 15.32B
-1.35%-0.14%-21.47%+68.89% 5.73B
+6.30%+60.43%+69.74% - 4.07B
+0.81%+7.25% - - 2.05B
+0.23%-5.47%+12.06%-39.15% 1.62B
-3.58%+18.29%-28.96% - 1.23B
+9.22%+13.76%+49.28%+152.91% 944M
-0.96%-3.13%+653.66%+896.77% 821M
Average +0.29%+9.87%+85.49%+214.22% 8.05B
Weighted average by Cap. -1.74%+5.52%-5.21%+79.75%

Financials

2024 2025
Net sales 398K 285K 244K 228K 209K 392K 27.28M 2.7M 1.05M 13.7M 1.07M 1.05M 45.32M 322K 231K 198K 185K 169K 318K 22.09M 2.18M 852K 11.1M 867K 848K 36.7M
Net income -3.13M -2.24M -1.92M -1.8M -1.64M -3.09M -215M -21.24M -8.29M -108M -8.43M -8.24M -357M -1.45M -1.04M -889K -831K -760K -1.43M -99.31M -9.82M -3.83M -49.89M -3.9M -3.81M -165M
Net Debt -375K -269K -230K -215K -197K -369K -25.7M -2.54M -992K -12.91M -1.01M -986K -42.7M -25.17K -18.04K -15.45K -14.44K -13.22K -24.82K -1.73M -171K -66.61K -867K -67.74K -66.26K -2.87M
Logo Monto Minerals Ltd
Opyl Limited is an Australia-based artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company, specialized in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored, actionable steps to address critical trial challenges, improving the likelihood of success. The Company is specialized in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-